title: ZAP-70 in CLL: towards standardization of a biomarker for patient management: history of clinical cytometry special issue.
authors.affiliation: FDA, Bethesda, MD 20892, USA. gemarti@helix.nih.gov
authors.forename: Gerald
authors.initials: G
authors.lastname: Marti
authors.forename: Alberto
authors.initials: A
authors.lastname: Orfao
authors.forename: Chuck
authors.initials: C
authors.lastname: Goolsby
mesh_terms: D014408:Biomarkers, Tumor / Q000032:analysis* / Q000592:standards; D005434:Flow Cytometry / Q000379:methods* / Q000592:standards*; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000175:diagnosis*; D011237:Predictive Value of Tests; D015203:Reproducibility of Results; D051746:ZAP-70 Protein-Tyrosine Kinase / Q000032:analysis* / Q000592:standards
chemical_list: D014408:Biomarkers, Tumor; D051746:ZAP-70 Protein-Tyrosine Kinase; C497261:ZAP70 protein, human